NanoString Courting Early-Access Customers for New Copy Number Variation Assays
June 17, 2010
NanoString Courting Early-Access Customers for New Copy Number Variation Assays
The CNV assays are the latest effort by NanoString to ferret out new applications for its nCounter platform, which the company initially developed as an alternative to both qPCR and microarrays for gene expression studies.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- NanoString, Broad Institute Strike Pact to Study Molecular Networks
November 18, 2009 / GenomeWeb Daily News - NanoString Technologies Files to Go Public
May 20, 2013 / GenomeWeb Daily News - Genotyping Patterns Hint at Ancient Back-to-Africa Migration
May 13, 2013 / GenomeWeb Daily News - Genomic Studies Reveal New Recurrently Mutated Genes in Meningioma
January 25, 2013 / GenomeWeb Daily News - Study Finds Digital PCR No Better than Real-Time PCR for Low-Level HIV Detection, Quantification
October 11, 2012 / PCR Insider